Music and ketamine each influence therapeutic outcomes, yet their combined use is rarely studied. This scoping review maps existing research on administering music alongside ketamine or esketamine in humans. Studies include healthy volunteers and patients of various ages, using different doses and treatment processes, with music played at varying times relative to drug administration. Research on music during ketamine anesthesia is included, as anesthesia drove early ketamine use. Recreational ketamine studies are excluded. The review is limited to English-language articles with no year restriction. It is the first comprehensive overview of music and ketamine/esketamine interplay, offering guidance for future study design.
The hippocampus and amygdala are brain regions involved in major depressive disorder (MDD) and its treatment. Preclinical work suggests antidepressants, including ketamine, can reverse stress-related changes in these areas. Clinical studies show reduced volumes in MDD, worsened by early life stress and repeated episodes. This analysis of structural MRI data from a prior double-blind, placebo-controlled, crossover trial examined changes in hippocampal and amygdalar subfield volumes after ketamine treatment. Participants included healthy volunteers and unmedicated individuals with treatment-resistant depression scanned at baseline and twice after a single ketamine or saline infusion. At 10 days post-infusion, a slight increase in whole left amygdalar volume was observed in the ketamine group among those with depression. No other differences were found between groups at either 3T or 7T field strength.